Helix Biologics
Dr. Lena Vogt · SVP Global Regulatory KB v1Deal stage
— where this deal is in its journey, first contact to closeDeal snapshot
Win chance, the value at stake, and how far this deal has come.
Win chance
Weighted to $420K
Value at stake
Full value vs. risk-adjusted.
Pipeline progress
Meeting Booked · 3d since touch
Helix Biologics is in Meeting Booked — $600K open, weighted to $420K at 70% win odds. Recommended next move: Follow up with Helix Biologics.
Recommended: Follow up with Helix Biologics
A quick read on this deal from your agent — where it stands and the smartest next move — so you're prepared before you call or email. The agent never reaches out on its own.
Deal value
$600K
The full amount if it closes.
Weighted
$420K
70% chance of closing
Owner
Suren DheenWho's running this deal — that's you.
Last activity
Your most recent logged call, email, or note — 3 days ago.
Next step scheduled: Jul 28, 2026
Agent — next best action for this deal
Follow up with Helix Biologics
You set a follow-up with Helix Biologics for 7/28/2026. Draft the recap with a concrete next step so it doesn't slip.
Recommended Services
Position Global Labeling Strategy against Helix Biologics's near-term regulatory milestones.
Single-pane monitoring across FDA, EMA and 120+ agencies.
Activity
- Meeting BookedJul 19, 2026 • 7:03 PM
Booked exec briefing for next Thursday.
Follow-up Jul 28, 2026Logged by Suren Dheen